GONZALES NOREEN R ET AL: "Minimizing the immunogenicity of antibodies for clinical application", TUMOR BIOLOGY, KARGER, BASEL, CH, vol. 26, no. 1, 28 February 2005 (2005-02-28), pages 31-43, XP008081934, ISSN: 1010-4283, DOI: 10.1159/000084184 (B1)

HARDING FIONA A ET AL: "The immunogenicity of humanized and fully human antibodies: Residual immunogenicity resides in the CDR regions", MABS, LANDES BIOSCIENCE, US, vol. 2, no. 3, 1 May 2010 (2010-05-01), pages 256-265, XP009137415, ISSN: 1942-0870, DOI: 10.4161/MABS.2.3.11641 (B1)

YOON SUN OK ET AL: "Construction, affinity maturation, and biological characterization of an anti-tumor-associated glycoprotein-72 humanized antibody", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, US, vol. 281, no. 11, 17 March 2006 (2006-03-17), pages 6985-6992, XP002495980, ISSN: 0021-9258, DOI: 10.1074/JBC.M511165200 (B1)

WO-A1-2009/032128 (B1)

Olivier Léger: "Humanization of Antibodies", , 12 July 2012 (2012-07-12), XP055032589, Retrieved from the Internet: URL:http://www.icpress.co.uk/etextbook/p74 3/p743_chap01.pdf [retrieved on 2012-07-12] cited in the application (B1)